Patrick G Enright - Net Worth and Insider Trading

Patrick G Enright Net Worth

The estimated net worth of Patrick G Enright is at least $554 Million dollars as of 2024-04-23. Patrick G Enright is the Director of Aimmune Therapeutics Inc and owns about 6,183,695 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $213 Million. Patrick G Enright is the Director, 10% Owner of Vera Therapeutics Inc and owns about 5,144,212 shares of Vera Therapeutics Inc (VERA) stock worth over $201 Million. Patrick G Enright is also the Director of Corcept Therapeutics Inc and owns about 6,108,328 shares of Corcept Therapeutics Inc (CORT) stock worth over $136 Million. Besides these, Patrick G Enright also holds Jazz Pharmaceuticals PLC (JAZZ) , Esperion Therapeutics Inc (ESPR) , Aptinyx Inc (APTX) . Details can be seen in Patrick G Enright's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Patrick G Enright has not made any transactions after 2023-08-14 and currently still holds the listed stock(s).

Transaction Summary of Patrick G Enright

To

Patrick G Enright Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick G Enright owns 21 companies in total, including Eargo Inc () , Aimmune Therapeutics Inc () , and Aptinyx Inc () among others .

Click here to see the complete history of Patrick G Enright’s form 4 insider trades.

Insider Ownership Summary of Patrick G Enright

Ticker Comapny Transaction Date Type of Owner
Eargo Inc 2020-10-15 10 percent owner
Aimmune Therapeutics Inc 2020-10-10 director
Aptinyx Inc 2020-01-10 director & 10 percent owner
Molecular Templates Inc 2019-11-25 10 percent owner
Jazz Pharmaceuticals PLC 2023-08-14 director & 10 percent owner
Inozyme Pharma Inc 2020-07-23 10 percent owner
89bio Inc 2019-11-08 10 percent owner
Vaxcyte Inc 2020-06-11 10 percent owner
Sierra Oncology Inc 2019-11-22 10 percent owner
Venus Concept Inc 2019-11-07 10 percent owner
Axonics Inc 2018-10-30 10 percent owner
Tricida Inc 2018-06-27 10 percent owner
Collegium Pharmaceutical Inc 2015-05-06 10 percent owner
Kala Bio Inc 2017-07-19 10 percent owner
Corcept Therapeutics Inc 2017-03-16 director & 10 percent owner
Esperion Therapeutics Inc 2015-03-19 director
Sequenom Inc 2007-06-22 director
Rapid Micro Biosystems Inc 2021-07-19 10 percent owner
Talaris Therapeutics Inc 2021-05-06 10 percent owner
Vera Therapeutics Inc 2023-02-06 director & 10 percent owner
Lexeo Therapeutics Inc 2023-11-02 10 percent owner

Patrick G Enright Latest Holdings Summary

Patrick G Enright currently owns a total of 6 stocks. Among these stocks, Patrick G Enright owns 6,183,695 shares of Aimmune Therapeutics Inc (AIMT) as of March 18, 2020, with a value of $213 Million and a weighting of 38.46%. Patrick G Enright owns 5,144,212 shares of Vera Therapeutics Inc (VERA) as of February 6, 2023, with a value of $201 Million and a weighting of 36.17%. Patrick G Enright also owns 6,108,328 shares of Corcept Therapeutics Inc (CORT) as of March 16, 2017, with a value of $136 Million and a weighting of 24.58%. The other 3 stocks Jazz Pharmaceuticals PLC (JAZZ) , Esperion Therapeutics Inc (ESPR) , Aptinyx Inc (APTX) have a combined weighting of 0.79% among all his current holdings.

Latest Holdings of Patrick G Enright

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AIMT Aimmune Therapeutics Inc 2020-03-18 6,183,695 34.49 213,275,641
VERA Vera Therapeutics Inc 2023-02-06 5,144,212 38.98 200,526,528
CORT Corcept Therapeutics Inc 2017-03-16 6,108,328 22.31 136,276,798
JAZZ Jazz Pharmaceuticals PLC 2023-08-14 20,946 108.79 2,278,715
ESPR Esperion Therapeutics Inc 2015-03-19 934,396 1.91 1,780,024
APTX Aptinyx Inc 2020-01-10 3,451,746 0.10 331,368

Holding Weightings of Patrick G Enright


Patrick G Enright Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick G Enright has made a total of 1 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 125,000 shares on March 18, 2020, which cost Patrick G Enright around $1 Million.

According to the SEC Form 4 filings, Patrick G Enright has made a total of 2 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vera Therapeutics Inc is the acquisition of 1,714,285 shares on February 6, 2023, which cost Patrick G Enright around $12 Million.

According to the SEC Form 4 filings, Patrick G Enright has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 269,955 shares on March 16, 2017, which brought Patrick G Enright around $3 Million.

More details on Patrick G Enright's insider transactions can be found in the Insider Trading History of Patrick G Enright table.

Insider Trading History of Patrick G Enright

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick G Enright Trading Performance

GuruFocus tracks the stock performance after each of Patrick G Enright's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick G Enright is 14.91%. GuruFocus also compares Patrick G Enright's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick G Enright within 3 months outperforms 9 times out of 13 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Patrick G Enright's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Patrick G Enright

Average Return

60.38%

Average return per transaction

Outperforming Transactions

58%

7 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.89 14.91 41.03 60.38 42.12 11.85
Relative Return to S&P 500(%) 11.16 12.4 35.69 50.59 32.26 0.59

Patrick G Enright Ownership Network

Ownership Network List of Patrick G Enright

No Data

Ownership Network Relation of Patrick G Enright


Patrick G Enright Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Patrick G Enright is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc () Insider Trades Summary

Over the past 18 months, Patrick G Enright made no insider transaction in Eargo Inc (). Other recent insider transactions involving Eargo Inc () include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.

Eargo Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Patrick G Enright Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick G Enright. You might contact Patrick G Enright via mailing address: Co Longitude Capital Partners Llc, 800 El Camino Real, Suite 220, Menlo Park Ca 94025.

Discussions on Patrick G Enright

No discussions yet.